News/January 21, 2026

Research suggests estrogen enhances gut pain sensitivity in female mice compared to males — Evidence Review

Published in Science, by researchers from University of California, San Francisco, Case Western Reserve University School of Medicine

Researched byConsensus— the AI search engine for science

Table of Contents

Women experience more severe gut pain than men, and a new study in mice suggests estrogen triggers nerve pathways in the gut that amplify this sensitivity. Related research generally supports a strong role for sex hormones, gut microbiota, and cell signaling in sex differences in gut pain, with the new findings building on and refining existing knowledge from previous studies (1–6,9,10).

  • Multiple studies have shown that sex hormones—especially estrogen—modulate gut pain sensitivity, often interacting with immune cells and gut microbiota, which aligns with the mechanism identified in the new study (1,4,6,9,10).
  • The involvement of rare gut cell types and hormone-triggered signaling pathways in visceral pain has also been highlighted in recent research, supporting the new study’s focus on estrogen-sensitive L-cells and serotonin signaling (3,5).
  • While some studies emphasize immune and microbiota influences or broader neuroendocrine factors, the new research adds molecular detail about how estrogen specifically amplifies gut pain, complementing and expanding upon prior work (2,4,5,9).

Study Overview and Key Findings

This new research addresses an ongoing question in gastroenterology: why do women experience irritable bowel syndrome (IBS) and related gut pain at higher rates and severity than men? Past research has recognized a sex bias in IBS prevalence and symptom severity, but the molecular and cellular mechanisms have remained unclear. The study, featured in the journal Science, investigates how estrogen interacts with specific gut cells and signaling pathways in mice, offering new insights into sex-specific pain amplification in the gastrointestinal tract.

Property Value
Study Year 2023
Organization University of California, San Francisco, Case Western Reserve University School of Medicine
Journal Name Science
Authors David Julius, Marissa Scavuzzo
Population Female and male mice
Methods Animal Study
Outcome Gut pain sensitivity, estrogen's effects on nerve activity
Results Estrogen increases gut pain sensitivity in female mice.

To contextualize these findings, we searched the Consensus database, which includes over 200 million research papers, for relevant studies on hormonal effects, gut pain, and sex differences. The following search queries were used:

  1. estrogen gut pain sensitivity gender differences
  2. female mice gut pain research
  3. hormonal effects gut pain severity

Key Topics and Findings

Topic Key Findings
How do sex hormones influence gut pain sensitivity and IBS symptomatology? - Estrogen and ovarian hormone fluctuations are linked to increased gut pain and IBS symptoms, especially during menstruation and hormone withdrawal phases (6 9 10).
- Sex hormones modulate visceral pain through effects on sensory and immune pathways in both mice and humans (1 4 6 9 10).
What is the role of gut microbiota and gut cell signaling in visceral pain and sex differences? - Gut microbiota influences visceral sensitivity, with germ-free mice showing altered pain responses; effects are modulated by sex hormones (2 4 5).
- Enterochromaffin and L-cells in the gut epithelium play a central role in pain signaling and show sex-biased activity (3 5).
Do immune and central nervous system factors contribute to sex differences in gut pain? - Female mice rely more on adaptive immune cells (T lymphocytes), while males rely on microglia for pain hypersensitivity (1).
- Central nervous system changes and stress responses differ by sex and hormonal status, impacting pain perception (2 8 9 10).
How do hormonal treatments and menstrual phases affect GI symptoms in women? - Women with IBS report more GI symptoms during menses and perimenopause, and hormonal therapies can modulate symptom severity (6 7 9 10).
- Some treatments, such as opioids and GnRH analogs, can exacerbate GI symptoms in women with endometriosis (7).

How do sex hormones influence gut pain sensitivity and IBS symptomatology?

Studies consistently indicate that sex hormones, particularly estrogen, play a significant role in modulating gut pain sensitivity and the clinical presentation of IBS. The new study's finding—that estrogen enhances pain signaling in the gut—aligns with and adds mechanistic detail to prior research showing that hormonal fluctuations can trigger or amplify gastrointestinal symptoms, especially in women.

  • Ovarian hormone levels are closely tied to changes in GI symptoms, with increased discomfort during periods of low estrogen such as menses and menopause (6).
  • Both animal and human studies indicate that estrogen and progesterone modulate visceral pain by influencing sensory and immune pathways (1 4 6 9 10).
  • The sex-specific effects of hormones necessitate tailored research and treatment approaches for women with IBS (9 10).
  • The new study provides cellular and molecular mechanisms for these clinical observations, demonstrating how estrogen acts on gut L-cells to trigger pain signaling.

What is the role of gut microbiota and gut cell signaling in visceral pain and sex differences?

Gut microbiota and specialized gut epithelial cells are increasingly recognized as critical mediators of visceral pain and its sex-specific features. The new study’s focus on estrogen-triggered L-cell signaling fits within a broader research context that highlights the importance of microbiota and cell signaling in pain pathways.

  • Absence or disruption of gut microbiota alters visceral sensitivity in both male and female mice, with some effects depending on sex hormones (2 4 5).
  • Enterochromaffin cells and L-cells are key sources of serotonin and peptide hormones that activate pain pathways; these cells exhibit sex-biased activity, with greater baseline engagement in females (3 5).
  • The new study advances this field by pinpointing a chain reaction in which estrogen-sensitive L-cells boost OLFR78 receptors and fullness hormone (PYY) release, leading to increased serotonin and pain signaling.
  • Findings suggest that dietary interventions (e.g., low-FODMAP diets) that affect gut microbiota may influence pain by modulating these hormonal and cell-signaling pathways (5).

Do immune and central nervous system factors contribute to sex differences in gut pain?

Research shows that immune cell types and central nervous system processes differ by sex in their contribution to pain hypersensitivity. The new study’s emphasis on estrogen and gut cell interactions complements, rather than replaces, these other pathways.

  • Female mice achieve pain hypersensitivity using adaptive immune cells (likely T lymphocytes), whereas male mice rely on microglia (1).
  • Central mechanisms, including altered brain region volumes and gene expression patterns, are associated with visceral pain and are influenced by both microbiota and sex (2 8 9 10).
  • The interplay between stress, the hypothalamic-pituitary-adrenal axis, and sex hormones further modulates chronic visceral pain (9 10).
  • The new study adds to this picture by detailing a peripheral (gut-based) mechanism, while immune and central pathways remain important contributors to sex differences in gut pain.

How do hormonal treatments and menstrual phases affect GI symptoms in women?

Fluctuations in ovarian hormones, menstrual cycle phases, and hormonal treatments all impact gastrointestinal symptoms, particularly in women with IBS or endometriosis. The new study’s insights into estrogen’s role in pain signaling help explain these clinical patterns.

  • Women with IBS experience more severe symptoms during menses and menopause, coinciding with declining hormone levels (6 9 10).
  • Hormonal treatments, such as GnRH analogs, may worsen GI symptoms in women with endometriosis, while estrogen-replacement can alleviate pain induced by ovariectomy in mice (4 7).
  • Most studies agree that sex hormone fluctuations, rather than absolute levels, are crucial in symptom modulation (6 8).
  • The new study suggests that targeting hormone-mediated pathways (e.g., PYY, OLFR78) could lead to more personalized treatments for hormone-sensitive gut pain.

Future Research Questions

While the new study provides valuable mechanistic insights into estrogen’s role in gut pain sensitivity, many questions remain. Future research is needed to determine how these findings translate to humans, how other factors like microbiota and immune signaling interact with hormone pathways, and how treatment approaches can be individualized.

Research Question Relevance
How do estrogen-mediated gut pain mechanisms in mice translate to humans? Mouse models provide mechanistic insights, but differences in human physiology, genetics, and microbiota composition may influence the applicability of these findings to human IBS (2 4 6).
What role do gut microbiota and diet play in modulating estrogen-sensitive gut pain? Gut bacteria and their metabolites interact with hormone-sensitive gut cells, influencing pain pathways; understanding these interactions could inform dietary or probiotic interventions (2 4 5).
Can targeting PYY or OLFR78 signaling offer effective therapies for IBS in women? The new study identifies PYY and OLFR78 as potential therapeutic targets, but further research is needed to evaluate their safety and efficacy in human patients (3 5 9 10).
How do hormonal changes across the lifespan (e.g. menopause, hormone therapy) affect gut pain sensitivity? Hormonal status changes throughout life and with medical treatments; understanding these effects is crucial for managing gut pain in diverse patient populations (6 7 9 10).
What are the interactions between immune signaling, central nervous system, and hormonal pathways in gut pain? Integrating insights from peripheral (gut), immune, and central nervous system mechanisms could provide a more comprehensive understanding of sex differences in gut pain (1 2 8 9 10).

Sources